EP1438320A1 - Nouveaux derives d'hydroxyalkyle indolocarbazole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent - Google Patents
Nouveaux derives d'hydroxyalkyle indolocarbazole, leur procede de preparation et les compositions pharmaceutiques qui les contiennentInfo
- Publication number
- EP1438320A1 EP1438320A1 EP02796813A EP02796813A EP1438320A1 EP 1438320 A1 EP1438320 A1 EP 1438320A1 EP 02796813 A EP02796813 A EP 02796813A EP 02796813 A EP02796813 A EP 02796813A EP 1438320 A1 EP1438320 A1 EP 1438320A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- formula
- compound
- linear
- branched
- compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/23—Heterocyclic radicals containing two or more heterocyclic rings condensed among themselves or condensed with a common carbocyclic ring system, not provided for in groups C07H19/14 - C07H19/22
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
Abstract
Description
Claims
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0113576 | 2001-10-22 | ||
FR0113576A FR2831169B1 (fr) | 2001-10-22 | 2001-10-22 | Nouveaux derives d'hydroxyalkyle indolocarbazole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
PCT/FR2002/003592 WO2003035663A1 (fr) | 2001-10-22 | 2002-10-21 | Nouveaux derives d'hydroxyalkyle indolocarbazole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
Publications (1)
Publication Number | Publication Date |
---|---|
EP1438320A1 true EP1438320A1 (fr) | 2004-07-21 |
Family
ID=8868539
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP02796813A Withdrawn EP1438320A1 (fr) | 2001-10-22 | 2002-10-21 | Nouveaux derives d'hydroxyalkyle indolocarbazole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
Country Status (18)
Country | Link |
---|---|
US (1) | US20040242508A1 (fr) |
EP (1) | EP1438320A1 (fr) |
JP (1) | JP2005509641A (fr) |
KR (1) | KR100588222B1 (fr) |
CN (1) | CN1253463C (fr) |
AR (1) | AR036898A1 (fr) |
BR (1) | BR0213403A (fr) |
CA (1) | CA2463923A1 (fr) |
EA (1) | EA006201B1 (fr) |
FR (1) | FR2831169B1 (fr) |
HK (1) | HK1072774A1 (fr) |
HU (1) | HUP0401885A2 (fr) |
MX (1) | MXPA04003741A (fr) |
NO (1) | NO20041761L (fr) |
NZ (1) | NZ532365A (fr) |
PL (1) | PL368237A1 (fr) |
WO (1) | WO2003035663A1 (fr) |
ZA (1) | ZA200402626B (fr) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080125403A1 (en) | 2004-04-02 | 2008-05-29 | Merck & Co., Inc. | Method of Treating Men with Metabolic and Anthropometric Disorders |
TWI499414B (zh) * | 2006-09-29 | 2015-09-11 | Lexicon Pharmaceuticals Inc | 鈉與葡萄糖第2型共同運輸體(co-transporter 2)的抑制物與其應用方法 |
US7846945B2 (en) * | 2007-03-08 | 2010-12-07 | Lexicon Pharmaceuticals, Inc. | Piperdine-based inhibitors of sodium glucose co-transporter 2 and methods of their use |
WO2012027331A1 (fr) | 2010-08-27 | 2012-03-01 | Ironwood Pharmaceuticals, Inc. | Compositions et procédés pour traiter ou prévenir un syndrome métabolique et des maladies et troubles associés |
US9616097B2 (en) | 2010-09-15 | 2017-04-11 | Synergy Pharmaceuticals, Inc. | Formulations of guanylate cyclase C agonists and methods of use |
CA2913737A1 (fr) | 2013-06-05 | 2014-12-11 | Synergy Pharmaceuticals, Inc. | Agonistes ultra-purs de guanylate cyclase c, leur procede de production et d'utilisation |
CN104031052B (zh) * | 2014-05-20 | 2016-06-08 | 中国科学院南海海洋研究所 | 抗生素Indimicins A–E及其制备方法和在制备抗肿瘤药物中的应用 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000064917A2 (fr) * | 1999-04-26 | 2000-11-02 | Advanced Life Sciences Inc. | Regioisomeres d'indolocarbazoles synthetiques et leurs utilisations |
US6703373B1 (en) * | 1999-09-10 | 2004-03-09 | Banyu Pharmaceutical Co., Ltd. | Indolopyrrolocarbazole derivatives and antitumor agents |
FR2801054B1 (fr) * | 1999-11-17 | 2003-06-13 | Adir | Nouveaux derives de 12,13-(pyranosyl)-indolo[2,3-a]pyrrolo [3,4-c]carbazole et 12,13-(pyranosyl)-furo[3,4-c]indolo [2,3-a]carbazole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
-
2001
- 2001-10-22 FR FR0113576A patent/FR2831169B1/fr not_active Expired - Fee Related
-
2002
- 2002-10-21 NZ NZ532365A patent/NZ532365A/en unknown
- 2002-10-21 JP JP2003538176A patent/JP2005509641A/ja not_active Ceased
- 2002-10-21 WO PCT/FR2002/003592 patent/WO2003035663A1/fr not_active Application Discontinuation
- 2002-10-21 MX MXPA04003741A patent/MXPA04003741A/es not_active Application Discontinuation
- 2002-10-21 HU HU0401885A patent/HUP0401885A2/hu unknown
- 2002-10-21 EP EP02796813A patent/EP1438320A1/fr not_active Withdrawn
- 2002-10-21 US US10/492,876 patent/US20040242508A1/en not_active Abandoned
- 2002-10-21 AR ARP020103953A patent/AR036898A1/es unknown
- 2002-10-21 KR KR1020047005995A patent/KR100588222B1/ko not_active IP Right Cessation
- 2002-10-21 CN CNB02820784XA patent/CN1253463C/zh not_active Expired - Fee Related
- 2002-10-21 EA EA200400533A patent/EA006201B1/ru unknown
- 2002-10-21 BR BR0213403-9A patent/BR0213403A/pt not_active IP Right Cessation
- 2002-10-21 CA CA002463923A patent/CA2463923A1/fr not_active Abandoned
- 2002-10-21 PL PL02368237A patent/PL368237A1/xx not_active Application Discontinuation
-
2004
- 2004-04-02 ZA ZA2004/02626A patent/ZA200402626B/en unknown
- 2004-04-29 NO NO20041761A patent/NO20041761L/no not_active Application Discontinuation
-
2005
- 2005-04-07 HK HK05102890A patent/HK1072774A1/xx not_active IP Right Cessation
Non-Patent Citations (1)
Title |
---|
See references of WO03035663A1 * |
Also Published As
Publication number | Publication date |
---|---|
ZA200402626B (en) | 2005-06-29 |
PL368237A1 (en) | 2005-03-21 |
US20040242508A1 (en) | 2004-12-02 |
AR036898A1 (es) | 2004-10-13 |
KR20040054735A (ko) | 2004-06-25 |
NO20041761L (no) | 2004-04-29 |
EA006201B1 (ru) | 2005-10-27 |
NZ532365A (en) | 2005-07-29 |
CA2463923A1 (fr) | 2003-05-01 |
HUP0401885A2 (hu) | 2004-12-28 |
MXPA04003741A (es) | 2004-07-23 |
WO2003035663A1 (fr) | 2003-05-01 |
FR2831169A1 (fr) | 2003-04-25 |
CN1253463C (zh) | 2006-04-26 |
JP2005509641A (ja) | 2005-04-14 |
EA200400533A1 (ru) | 2004-08-26 |
KR100588222B1 (ko) | 2006-06-12 |
HK1072774A1 (en) | 2005-09-09 |
BR0213403A (pt) | 2004-11-03 |
FR2831169B1 (fr) | 2003-12-12 |
CN1571793A (zh) | 2005-01-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2406263B1 (fr) | Derivés de pyrazolo[1,5-a]-1,3,5-triazines, leur preparation et leur application en thérapeutique | |
HUT67496A (en) | Methylen-oxindole derivatives, their preparation and pharmaceutical compositions compsiring them | |
EP0839149B9 (fr) | Derives de la galanthamine, leur procede de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant | |
EP1558612B1 (fr) | Derives d'imidazopyridine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent | |
CH633796A5 (fr) | Dipyridoindoles therapeutiquement actifs. | |
CA2436958A1 (fr) | Derives d'acyclonucleosides pyrimidiniques, leur procede de preparation et leur utilisation | |
WO2003002563A1 (fr) | Derives de pyrido-pyrido-pyrrolo pyrrolo-indole et pyrido-pyrrolo pyrrolo carbazole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent | |
EP1101770B1 (fr) | Nouveaux dérives de 12,13-(pyranosyl)-indolo(2,3-a)pyrrolo(3,4-c)carbazole et 12,13-(pyranosyl)-furo(3,4-c)indolo(2,3-a)carbazole, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent | |
EP1438320A1 (fr) | Nouveaux derives d'hydroxyalkyle indolocarbazole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent | |
EP0117959B1 (fr) | Nouveaux dérivés de la nitrosourée, leur procédé de préparation et les compositions pharmaceutiques les renfermant | |
EP0318392B1 (fr) | Nouveaux dérivés N-(vinblastinoyl-23) d'acide amino-1 méthylphosphonique, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent | |
FR2845996A1 (fr) | Nouveaux derives de[3,4-a:3,4-c]carbazole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent | |
EP0699679A1 (fr) | Nouveaux composés tétrahydropyraniques, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent | |
CA2896209A1 (fr) | 3,5-diaryl-azaindoles comme inhibiteurs de la proteine dyrk1a pour le traitement des deficiences cognitives liees au syndrome de down et a la maladie d'alzheimer | |
FR2701261A1 (fr) | Nouveaux composés glucuronides de la diosmétine, leur procédé de préparation et les compositions pharmaceutiques les renfermant. | |
EP0412015B1 (fr) | Nouveaux dérivés N-(vincristinoyl-23) et N-(noranhydro-5' vinblastinoyl-23) d'acide amino-1 méthylphosphonique, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent | |
CA1204770A (fr) | Derives fluores de diaminoalkene | |
FR2758562A1 (fr) | Nouveaux derives d'acides mixtes aminobenzyliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent | |
CH609056A5 (en) | Process for the preparation of pyrimidines | |
FR2781482A1 (fr) | Nouveaux derives de 8h-thieno-[2,3-b]pyrrolizine-8-one, leur procede de preparation et les compositions pharmaceutiques qui les contiennent | |
CA2033798A1 (fr) | Derives de la thymidine, leur preparation et les compositions qui les contiennent | |
WO1986007057A1 (fr) | Derives methyles de bis 7h pyridocarbazoles methyles et compositions pharmaceutiques les contenant | |
FR2902792A1 (fr) | Nouveaux derives cinnamates de tetrahydro-7h-pyrano(2,3-c)acridin-7-one, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20040414 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LI LU MC NL PT SE SK TR |
|
AX | Request for extension of the european patent |
Extension state: AL LT LV MK RO SI |
|
RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: BIZOT-ESPIARD, JEAN-GUY Inventor name: RENARD, PIERRE Inventor name: PFEIFFER, BRUNO Inventor name: PIERRE, ALAIN Inventor name: HICKMAN, JOHN Inventor name: MOREAU, PASCALE Inventor name: MARMINON, CHRISTELLE Inventor name: PRUDHOMME, MICHELLE |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20061104 |